68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives
Cancers · 29.04.2025 · 17 (9) · 1504
DOI: 10.3390/cancers17091504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.04.2025. Verfasst von Luca Urso und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Molecular imaging, especially PET, has advanced significantly, shifting from metabolic radiotracers like 2-deoxy-2-[18F]fluoro-D-glucose [18F]FDG to target-specific probes. Among these, αvβ6-integrin has emerged as a promising target in cancer and non-cancer diseases. This review focuses on the radiochemical properties and initial clinical applications of the [68Ga]Ga-Trivehexin PET probe.
Methods
The literature review on [68Ga]Ga-Trivehexin systematically evaluated both preclinical and clinical studies, with particular emphasis on its radiochemical characteristics and preliminary clinical applications, while highlighting advancements, associated challenges, and the potential for future developments in the field.
Results
This study highlights the significant advancements achieved with [68Ga]Ga-Trivehexin in the field of molecular imaging. The optimized multimeric system has substantially enhanced the radiotracer’s pharmacokinetic properties, binding affinity, and selectivity for αvβ6 integrin, demonstrating up to an 18-fold improvement compared to previous monomeric tracers. The synthesis protocol has been refined to achieve high radiochemical purity (>95%), essential for safe clinical use. Preliminary clinical applications, particularly in head and neck cancer (HNC) and pancreatic ductal adenocarcinoma (PDAC), have shown promising results, with high detection rates and improved differential diagnosis compared to [18F]FDG. Furthermore, [68Ga]Ga-Trivehexin PET/CT has shown potential in non-oncological conditions, such as idiopathic pulmonary fibrosis (IPF) and primary hyperthyroidism, suggesting broader clinical applicability. Conclusions: [68Ga]Ga-Trivehexin is a promising PET probe for imaging αvβ6-integrin in cancers and non-oncological diseases like idiopathic pulmonary fibrosis (IPF) and primary hyperparathyroidism (PHP).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Medicine, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy.
- Nuclear Medicine Unit, Department of Onco-Haematology, Via Aldo Moro 8, 44124 Ferrara, Italy.
- Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Department of Nuclear Medicine, Hacettepe University, 06230 Ankara, Turkey.
ORCID-Profile: Luca Urso, Giorgia Speltri, Murat Tuncel, Ilham Badrane, Licia Uccelli, Petra Martini, Corrado Cittanti, Alessandra Boschi
Zitieren
APA
Urso, L., Napolitano, R., Speltri, G., Tuncel, M., Badrane, I., Uccelli, L., Porto, F., Martini, P., Niorettini, A., Cittanti, C., Bartolomei, M., & Boschi, A. (2025). 68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives. Cancers, 17(9), 1504. https://doi.org/10.3390/cancers17091504
Vancouver
Urso L, Napolitano R, Speltri G, Tuncel M, Badrane I, Uccelli L, et al. 68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives. Cancers. 2025;17(9):1504. doi:10.3390/cancers17091504
BibTeX
@article{Urso2025,
author = {Urso, Luca and Napolitano, Rebecca and Speltri, Giorgia and Tuncel, Murat and Badrane, Ilham and Uccelli, Licia and Porto, Francesca and Martini, Petra and Niorettini, Alessandro and Cittanti, Corrado and Bartolomei, Mirco and Boschi, Alessandra},
title = {68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives},
journal = {Cancers},
year = {2025},
volume = {17},
number = {9},
pages = {1504},
doi = {10.3390/cancers17091504}
}
EUVIMED